Stock Market Today, Feb.: ImmunityBio Surges on Anktiva
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Index funds generally provide more control over allocations than target date funds, which automate drift. This intro explains what that means in practice.
28,480 articlesBiotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Industrial stocks can offer big turns with the right cycle. This guide shows how to analyze backlog, margins, and ris...
As AI shifts the tech landscape, Microsoft sits at the center of the action. This guide breaks down whether will micr...
Traders worldwide can compete in a two-week sprint using Leveraged's Sprint accounts. The top performers will face of...
Inflation can erode returns, but there are smarter ways to shield your portfolio. This guide shows two durable energy...
A debt-free couple earning $100,000 a year reports zero savings, prompting a rare on-air moment of doubt from Dave Ra...
The Commerce Department imposed export controls on Anthropic’s latest AI models after a probe described as a narrow j...
A prominent investment advisor added a sizable CMPX position, signaling strong conviction in Compass Therapeutics. He...
As Haverty prepares for its 2025 earnings release, investors seek clarity on margins, store performance, and forward ...
The Supreme Court decision clears a path for roughly $180 billion in tariff refunds to importers, yet Goldman Sachs c...
The internet computer (icp) tumbles about 10% in a broad crypto selloff, weakening after Coinbase removed several ICP...
Micron stock has swung on memory cycles, auto-chip demand, and big backlog talk. This article examines whether a deal...